MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 81 to 100 of 5,858 approvalsPage 5 of 293

LENALIDOMIDE GRINDEKS HARD CAPSULE 15MG

Approval Number: SIN17158P
Approval: Jan 2, 2025
GOLDPLUS UNIVERSAL PTE LTD

LENALIDOMIDE GRINDEKS HARD CAPSULE 5MG

Approval Number: SIN17160P
Approval: Jan 2, 2025
GOLDPLUS UNIVERSAL PTE LTD

LENALIDOMIDE GRINDEKS HARD CAPSULE 25MG

Approval Number: SIN17157P
Approval: Jan 2, 2025
GOLDPLUS UNIVERSAL PTE LTD

LENALIDOMIDE GRINDEKS HARD CAPSULE 10MG

Approval Number: SIN17159P
Approval: Jan 2, 2025
GOLDPLUS UNIVERSAL PTE LTD

ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML

Approval Number: SIN17155P
Approval: Dec 31, 2024
PFIZER PRIVATE LIMITED

ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML

Approval Number: SIN17156P
Approval: Dec 31, 2024
PFIZER PRIVATE LIMITED

CONJUPRI TABLETS 5MG

Approval Number: SIN17153P
Approval: Dec 26, 2024
LOTUS INTERNATIONAL PTE. LTD.

CONJUPRI TABLETS 2.5MG

Approval Number: SIN17154P
Approval: Dec 26, 2024
LOTUS INTERNATIONAL PTE. LTD.

VOYDEYA FILM-COATED TABLET 100 MG + 100 MG

Approval Number: SIN17151P
Approval: Dec 26, 2024
ASTRAZENECA SINGAPORE PTE LTD

VOYDEYA FILM-COATED TABLET 100 MG + 50 MG

Approval Number: SIN17152P
Approval: Dec 26, 2024
ASTRAZENECA SINGAPORE PTE LTD

TAVNEOS HARD CAPSULE 10MG

Approval Number: SIN17150P
Approval: Dec 24, 2024
AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.

AQUIPTA TABLET 60MG

Approval Number: SIN17146P
Approval: Nov 29, 2024
ABBVIE PTE. LTD.

AQUIPTA TABLET 10MG

Approval Number: SIN17145P
Approval: Nov 29, 2024
ABBVIE PTE. LTD.

PREZEL 75 CAPSULE 75MG

Approval Number: SIN17143P
Approval: Nov 28, 2024
GOLDPLUS UNIVERSAL PTE LTD

PREZEL 150 CAPSULE 150MG

Approval Number: SIN17144P
Approval: Nov 28, 2024
GOLDPLUS UNIVERSAL PTE LTD

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.